Trials / Completed
CompletedNCT02051972
The LEADLESS Observational Study
Nanostim Study for a Leadless Cardiac Pacemaker System
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 491 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to confirm clinical performance and safety of the Nanostim leadless cardiac pacemaker system within its intended use and according to its instructions for use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Implanted with a Nanostim leadless pacemaker system |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2017-03-01
- Completion
- 2021-12-22
- First posted
- 2014-01-31
- Last updated
- 2025-06-06
- Results posted
- 2025-06-06
Locations
32 sites across 7 countries: Czechia, France, Germany, Italy, Netherlands, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT02051972. Inclusion in this directory is not an endorsement.